Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study

Claus Anders Bertelsen(University of Copenhagen), Ismail Gögenür(University of Copenhagen), Jutaka Tenma(Bispebjerg Hospital), Michael Wilhelmsen(University of Copenhagen), Else Refsgaard Iversen(University of Copenhagen), Anders Kirkegaard-Klitbo(University of Copenhagen), L. A. Rasmussen(University of Copenhagen), Jens Erik Jansen(University of Copenhagen), Peter Ingeholm(University of Copenhagen), Lars Vedel Jepsen(University of Copenhagen), Bent Bruun Kristensen(University of Copenhagen), Birgitte Bols(University of Copenhagen), Anders Ulrich Neuenschwander(University of Copenhagen)
The Lancet Oncology
December 30, 2014
10.1016/s1470-2045(14)71168-4
Cited by 477

Related Papers

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k
The Safety of Melatonin in Humans
|Clinical Drug Investigation|2015|464
Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery
|JAMA Surgery|2023|434
Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation
|BMC Cancer|2019|362
Clinical pharmacokinetics of melatonin: a systematic review
|European Journal of Clinical Pharmacology|2015|306